These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 7884325)

  • 1. Monoclonal antibody EG2 reactivity cannot be used as an immunohistochemical activation marker for eosinophils.
    Jahnsen FL; Brandtzaeg P
    J Leukoc Biol; 1995 Mar; 57(3):513-4. PubMed ID: 7884325
    [No Abstract]   [Full Text] [Related]  

  • 2. Erroneous immunohistochemical application of monoclonal antibody EG2 to detect cellular activation.
    Jahnsen FL; Halstensen TS; Brandtzaeg P
    Lancet; 1994 Nov; 344(8935):1514-5. PubMed ID: 7968154
    [No Abstract]   [Full Text] [Related]  

  • 3. Reactivity of monoclonal antibodies EG1 and EG2 with eosinophils and their granule proteins.
    Nakajima H; Loegering DA; Kita H; Kephart GM; Gleich GJ
    J Leukoc Biol; 1999 Sep; 66(3):447-54. PubMed ID: 10496315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibody EG2 does not provide reliable immunohistochemical discrimination between resting and activated eosinophils.
    Jahnsen FL; Brandtzaeg P; Halstensen TS
    J Immunol Methods; 1994 Sep; 175(1):23-36. PubMed ID: 7930638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of blood EG2+ eosinophils in patients with bronchial asthma.
    Monteseirín J; Llamas E; Muñoz F; Bono MJ; Conde J
    Allergol Immunopathol (Madr); 1993; 21(3):97-9. PubMed ID: 8356938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of monoclonal antibodies against major basic protein (BMK-13) and eosinophil cationic protein (EG1 and EG2) for quantifying eosinophils in bronchial biopsies from atopic asthma.
    Moqbel R; Barkans J; Bradley BL; Durham SR; Kay AB
    Clin Exp Allergy; 1992 Feb; 22(2):265-73. PubMed ID: 1373987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Eosinophil activation evaluated by using a anti-human secreted form of ECP antibody (EG2)].
    Kobayashi H; Maeda S; Tamura M; Sakamoto S
    Nihon Rinsho; 1993 Mar; 51(3):626-30. PubMed ID: 8492435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The changes of EG1 and EG2 positive eosinophils and their clinical significance in asthmatics].
    Huang H; Xu J; Zhong N
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Oct; 21(10):612-4. PubMed ID: 11477881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemically stained activated eosinophils in sputum in patients with asthma.
    Jang AS; Choi IS; Park CS
    Respiration; 2000; 67(2):183-8. PubMed ID: 10773791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunostaining with monoclonal antibodies to eosinophil cationic protein (EG1 and EG2) does not distinguish between resting and activated eosinophils in formalin-fixed tissue specimens.
    Jahnsen F; Halstensen TS; Brandtzaeg P
    Adv Exp Med Biol; 1995; 371A():283-6. PubMed ID: 8525926
    [No Abstract]   [Full Text] [Related]  

  • 11. Characterization of the eosinophil granule proteins recognized by the activation-specific antibody EG2.
    Rosenberg HF; Tiffany HL
    J Leukoc Biol; 1994 Oct; 56(4):502-6. PubMed ID: 7930947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibodies against eosinophils in liver allograft rejection.
    Ben-Ari Z; Dhillon AP; Moqbel R; Garwood L; Booth D; Rolles K; Davidson B; Burroughs AK
    Liver Transpl Surg; 1996 Jan; 2(1):46-51. PubMed ID: 9346627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole-blood flow-cytometric analysis of eosinophil EG2 expression as a marker of the pathological conditions of asthma.
    Kuwasaki T; Chihara J; Kayaba H; Kamata Y; Oyamada H; Saito N; Shioya T; Sasaki M; Kagaya M; Tsuda A
    Int Arch Allergy Immunol; 1998 Sep; 117 Suppl 1():77-80. PubMed ID: 9758904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The respiratory burst activity of activated eosinophils in atopic asthmatics.
    Tsai JJ; Kao MH; Han SH
    Int Arch Allergy Immunol; 1999 May; 119(1):38-44. PubMed ID: 10341319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of RANTES on intracellular expression of EG2 antigen in eosinophils.
    Kakazu T; Chihara J; Saito A; Higashimoto I; Yamamoto T; Kurachi D; Nakajima S
    Int Arch Allergy Immunol; 1995; 108 Suppl 1():43-4. PubMed ID: 7549521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibodies specific for guinea pig eosinophil major basic protein: their use in an ELISA, immunocytochemistry and flow cytometry.
    Hunt TC; Summers JA; Campos MG; Rimmer SJ; Sturton G; Palfai S; Church MK
    Clin Exp Allergy; 1993 May; 23(5):425-34. PubMed ID: 8334540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patients with psoriasis have elevated levels of serum eosinophil cationic protein and increased numbers of EG2 positive eosinophils in the duodenal stroma.
    Michaëlsson G; Kraaz W; Gerdén B; Hagforsen E; Lundin IP; Lööf L; Sj-oberg O; Scheynius A
    Br J Dermatol; 1996 Sep; 135(3):371-8. PubMed ID: 8949428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibodies to human eosinophil plasma membrane antigens enhance the secretion of eosinophil cationic protein.
    Tai PC; Capron M; Bakes DM; Barkans J; Spry CJ
    Clin Exp Immunol; 1986 Mar; 63(3):728-37. PubMed ID: 3708911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of cytokine RANTES on induction of activated eosinophils].
    Kakazu T; Chihara J; Saito A; Nakajima S
    Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Nov; 33(11):1226-32. PubMed ID: 8583714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The degree of natural allergen exposure modifies eosinophil activity markers in the circulation of patients with mild asthma.
    Fernvik E; Grönneberg R; Lundahl J; Hed J; Andersson O; Johansson SG; Halldén G
    Allergy; 1996 Oct; 51(10):697-705. PubMed ID: 8904997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.